Valuation: BioElectronics Corporation

Market Cap 1.24Cr 1.08Cr 99.24L 92.5L 1.75Cr 117.61Cr 1.78Cr 12Cr 4.63Cr 58Cr 4.64Cr 4.54Cr 199.22Cr P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 2.57Cr 2.25Cr 2.06Cr 1.92Cr 3.65Cr 244.65Cr 3.7Cr 25Cr 9.63Cr 120.26Cr 9.64Cr 9.44Cr 414.39Cr EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 month-25.00%
6 months-25.00%
Current year-25.00%
1 week 0
Extreme 0.000265
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Sales & Marketing - 01/09/2017
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 15/11/2019
Chairman 85 15/06/2020
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+50.00%-50.00% 74.12L
+1.97%+2.03%+21.92%+0.55% 19TCr
+5.87%+5.27%-21.76%+27.59% 15TCr
+2.17%+0.89%-2.59%-16.62% 14TCr
+4.83%+2.06%-56.73%-15.23% 6.71TCr
+2.59%+3.95%+22.89%+3.75% 5.43TCr
+0.03%+2.19%-25.17%-30.62% 4.46TCr
+0.31%+1.30%+8.30%+42.29% 3.72TCr
-2.02%-3.91%+7.67%+9.36% 3.69TCr
+4.24%+4.66%-18.42%-3.15% 3.02TCr
Average +2.02%+2.47%-1.39%-3.21% 7.56TCr
Weighted average by Cap. +2.80%+3.44%-4.01%+2.09%

Financials

2020 2021
Net sales 8L 7L 7L 6L 11.78L 7.9Cr 11.96L 80.01L 31.1L 3.88Cr 31.14L 30.47L 13Cr 16.09L 14.07L 12.93L 12.05L 22.86L 15Cr 23.21L 1.55Cr 60.35L 7.53Cr 60.41L 59.12L 26Cr
Net income -11.6L -10.14L -9L -9L -16.47L -11Cr -16.72L -1.12Cr -43.48L -5.43Cr -43.53L -42.6L -19Cr -3L -3L -2L -2L -4L -2.76Cr -4L -27.95L -10.87L -1.36Cr -10.88L -10.65L -4.67Cr
Net Debt 1.31Cr 1.14Cr 1.05Cr 97.86L 1.86Cr 124.42Cr 1.88Cr 13Cr 4.9Cr 61Cr 4.91Cr 4.8Cr 210.76Cr 1.33Cr 1.17Cr 1.07Cr 99.91L 1.89Cr 127.03Cr 1.92Cr 13Cr 5Cr 62Cr 5.01Cr 4.9Cr 215.17Cr
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
02/26/02 $0.000300 0.00% 25,40,317
01/26/01 $0.000300 0.00% 1,98,76,498
30/26/30 $0.000300 +20.00% 93,58,333
29/26/29 $0.000250 0.00% 69,30,833
  1. Stock Market
  2. Stocks
  3. BIEL Stock